VanEck Associates’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-493
| Closed | -$4K | – | 1399 |
|
|
2024
Q3 | $4K | Sell |
493
-145
| -23% | -$1.18K | ﹤0.01% | 1360 |
|
|
2024
Q2 | $9K | Hold |
638
| – | – | ﹤0.01% | 1344 |
|
|
2024
Q1 | $30K | Buy |
638
+45
| +8% | +$2.12K | ﹤0.01% | 1304 |
|
|
2023
Q4 | $40K | Buy |
593
+108
| +22% | +$7.29K | ﹤0.01% | 1297 |
|
|
2023
Q3 | $35K | Hold |
485
| – | – | ﹤0.01% | 1305 |
|
|
2023
Q2 | $36K | Buy |
485
+260
| +116% | +$19.3K | ﹤0.01% | 1319 |
|
|
2023
Q1 | $12K | Sell |
225
-156
| -41% | -$8.32K | ﹤0.01% | 1365 |
|
|
2022
Q4 | $26K | Buy |
381
+62
| +19% | +$4.23K | ﹤0.01% | 1345 |
|
|
2022
Q3 | $39K | Buy |
319
+163
| +104% | +$19.9K | ﹤0.01% | 1280 |
|
|
2022
Q2 | $15K | Buy |
156
+52
| +50% | +$5K | ﹤0.01% | 1323 |
|
|
2022
Q1 | $17K | Hold |
104
| – | – | ﹤0.01% | 1320 |
|
|
2021
Q4 | $35K | Buy |
+104
| New | +$35K | ﹤0.01% | 1310 |
|